Mesalamine suppositories are indicated for the treatment of mildly to moderately active ulcerative proctitis
The event will be attended by 35,000+ industry professionals
The company’s “greener” initiatives emphasize eco-friendly excipients and energy-efficient manufacturing processes that reduce environmental impact without compromising product quality
Yesintek and Yesintek I.V. are approved for the treatment of moderate to severe plaque psoriasis in adults and pediatric patients
The initial $100 million will fund a state-of-the-art hard-shell capsule facility in Atlanta
IKS Health's innovative solution orchestrates a roll out of critical operations functions into a unified and efficient connected workflow
The new cGMP-compliant HPAPI Laboratory is equipped with state-of-the-art isolators designed to meet Occupational Exposure Band 5 (OEB-5) requirements
Subscribe To Our Newsletter & Stay Updated